About this trial
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age <= 18 years old
Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity)
Diagnosed and Treated in China
Disqualifiers
Disagreement of involving in this study by the patient or his/her family.
Trial population
Chinese children with pediatric rheumatic and immunologic diseases enrolled from CAPRID centers.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of Enrolled Patients
Total number of patients with pediatric rheumatic and immunologic diseases enrolled in the registry
Secondary outcomes
Physician Global Assessment
Visual Analog Score measurement of disease activity by physicians. The minimum value is 0 and the maximum is 10.
Patient or Parent Global Assessment
Visual Analog Score measurement of disease activity by patient's parent or patient him or her self (above 8 years old). The minimum value is 0 and the maximum is 10.
Proportion of Participants with Clinically Inactive Disease
Defined by normal disease activity indexes (if available) and normal inflammatory markers (erythrocyte sedimentation rate and C-reactive protein). Disease activity indexes include Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) for systemic lupus erythematosus; Juvenile Arthritis Disease Activity Score (JADAS)-27 for juvenile idiopathic arthritis, Pediatric Vasculitis Activity Score (PVAS) for vasculitis; Manual Muscle Testing(MMT)8, Childhood Myositis Assessment Scale (CMAS) for juvenile dermatomyositis, Sjögren's syndrome disease activity index (ESSDAI) for Sjögren's syndrome, Modified Rodnan Skin Score for scleroderma.
Childhood Health Assessment Questionnaire (CHAQ)
Composite measure of functional disability, score from 0 (no disability) to 3 (severe disability)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Peking Union Medical College Hospital
Lead sponsor
Children's Hospital of Chongqing Medical University
Collaborator
Central South University
Collaborator
Beijing Children's Hospital
Collaborator
Shenzhen Children's Hospital
Collaborator
Children's Hospital of Nanjing Medical University
Collaborator
The University of Hong Kong
Collaborator
Zhejiang University
Collaborator
Peking University Third Hospital
Collaborator